Intronic variants in the long non-coding RNA CDKN2B-AS1 are strongly associated with the risk of coronary artery disease in the Northern Tribes of Tanzania

Gökçe Akan, Peter Kisenge, Tulizo Shemu Sanga, Erasto V. Mbugi, Mehmet Kerem Türkcan, Mohammed Janabi, Fatmahan AtalarTanzania 2020 · DOI

Abstract

Sub-Saharan Africa is facing a rising epidemic of coronary artery disease (CAD). The chromosome locus 9p21.3, containing the long non-coding RNA CDKN2B-AS1, is a known hotspot for CAD risk, yet its role in African populations remains understudied. This study evaluated common polymorphisms in this locus among 155 Tanzanian CAD patients from different regions. Results showed significant differences in genotype and allele frequencies for rs10757274, rs10757278, and rs10811656 between Northern (N-CAD) and other (R-CAD) regions. A novel three-marker risk haplotype (G-G-G) was identified as overrepresented in the N-CAD group. Combining genetic risk factors with non-genetic factors improved the diagnostic model's AUC from 0.730 to 0.784, suggesting these variants are significant biomarkers for CAD in Northern Tanzania.

Introduction

Coronary artery disease (CAD) is becoming a leading cause of morbidity in Sub-Saharan Africa due to rapid urbanization and lifestyle changes. While the 9p21.3 locus is a well-established risk factor in European and Asian populations, its impact in African cohorts is less clear and often inconsistent across regions. This study investigates the association of variants within the CDKN2B-AS1 (also known as ANRIL) gene with CAD risk in the diverse tribal populations of Tanzania, specifically focusing on the Northern region where the Chagga tribe predominates.

Methods

A cross-sectional study was conducted with 155 Tanzanian CAD patients recruited from the Jakaya Kikwete Cardiac Institute. Participants were categorized into two groups: 90 from the Northern region (N-CAD) and 65 from other regions (R-CAD: South, East, West, and Central). Biochemical profiles, including BMI, fasting glucose, and lipid levels, were recorded. Genotyping of six specific Single Nucleotide Polymorphisms (SNPs) at the 9p21.3 locus was performed using Quantitative Real-Time PCR (qRT-PCR) with the LightSNiP typing assay. Haplotype analysis was conducted using Haploview 4.2, and the predictive value of genetic markers was assessed using Area Under the Curve (AUC) Receiver Operating Characteristic (ROC) models.

Results

The study revealed that patients from Northern Tanzania exhibited significantly higher clinical risk factors and a distinct genetic profile compared to those from other regions. Three specific SNPs—rs10757274, rs10757278, and rs10811656—showed strong statistical associations with CAD risk (p < 0.05).

Table 1: Genotypic and Allelic Frequencies of 9p21.3 SNPs in Tanzanian CAD Patients.

The G allele of rs10757274 was particularly notable, associated with a 3.07-fold increase in CAD risk in the Northern group (95% CI: 1.89–4.97). Furthermore, a novel three-marker risk haplotype (G-G-G, comprising rs1333049, rs10757274, and rs10757278) was identified as significantly overrepresented in the N-CAD group. Integrating these genetic markers into a clinical risk model significantly enhanced diagnostic accuracy.

Table 2: Comparison of AUC for Non-Genetic and Combined Risk Models.

As shown in Table 2, the baseline model using only non-genetic factors (BMI, cholesterol, triglycerides, glucose) yielded an AUC of 0.730. The addition of the three key SNPs improved the AUC to 0.784 (p < 0.0001), indicating a robust improvement in diagnostic performance.

Discussion and Conclusion

The findings highlight significant intra-country genetic and phenotypic diversity within Tanzania. Interestingly, the SNP frequencies in this Tanzanian cohort were more similar to European populations than to other African regions, suggesting complex ancestral links. Mechanistically, these intronic variants in CDKN2B-AS1 likely disrupt transcription factor binding sites (e.g., for STAT1), modulating inflammatory signaling pathways critical to atherosclerosis.

The study concludes that CDKN2B-AS1 variants are potent risk markers for CAD in Northern Tanzania. Their inclusion in clinical models provides a "good" level of diagnostic accuracy, potentially serving as prognostic biomarkers. While limited by a relatively small sample size and the lack of a healthy control group, this research provides a vital foundation for personalized cardiovascular medicine in East Africa.

Summary updated

Abstract

Introduction: Sub-Saharan Africa (SSA) is facing a rising epidemic of non-communicable diseases including the coronary artery disease (CAD) ranking at the top of the list. Chromosome locus 9p21.3 containing CDKN2B antisense RNA 1 (CDKN2B-AS1), identified in many genome-wide association studies for coronary artery disease (CAD), encompasses multiple single nucleotide polymorphisms (SNPs). This study aimed to conduct the first genetic study evaluating the common polymorphisms in 9p21.3 locus in Tanzanian CAD patients from different regions of Tanzania and their associations with CAD risk factors.&#x0D; Material and Methods: A total of 90 patients from Northern region (N-CAD) of Tanzania and 65 patients from other regions (South, East, West and Central) (R-CAD) were included in the study. Further the biochemical analysis the genotyping of common variants was performed with the LightSNiP typing assay using qRT-PCR method. &#x0D; Results: Our analyses revealed that both genotype and allele frequencies of rs10757274, rs10757278 and rs10811656 were significantly different between the groups (p&lt;0.05, respectively). We identified that one previously undescribed three-marker haplotype (rs1333049, rs10757274 and rs10757278) encompassing CDKN2B-AS1 was overrepresented (G-G-G, the risk haplotype, p&lt;0.05) in N-CAD group compared to R-CAD group. The AUC of a risk model based on non-genetic factors was 0.730 (0.654-0.797) and the combination with genetic risk factors improved the AUC to 0.784 (95%CI=0.713-0.844, p&lt;0.0001).&#x0D; Conclusion: Our results identified the presence of a novel three-marker haplotype having a significant association with CAD in Northern Tanzania. Moreover, combination of the nongenetic and genetic risk models were demonstrated to indicate good diagnostic accuracy for CAD in Northern Tanzania.
BibTeX
@inproceedings{akan2020intronic,
  author = {Gökçe Akan and Peter Kisenge and Tulizo Shemu Sanga and Erasto V. Mbugi and Mehmet Kerem Türkcan and Mohammed Janabi and Fatmahan Atalar},
  title = {{Intronic variants in the long non-coding RNA CDKN2B-AS1 are strongly associated with the risk of coronary artery disease in the Northern Tribes of Tanzania}},
  booktitle = {Tanzania},
  year = {2020},
  doi = {10.4314/thrb.v21i1.3},
}
Figure